- Acumen Powered by Robins Kaplan LLP®
- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Fiduciary Disputes
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
March 16, 2023Second Circuit Affirms Record $5.6 Billion Recovery in Antitrust Case
March 10, 2023Robins Kaplan Announces $28 Million Settlement in Case Against For-Profit College’s Directors & Officers
March 9, 2023Robins Kaplan LLP Launches New Professional Development Program
March 19-22, 2023PLRB 2023 Claims Conference
March 29-30, 2023ACI Managed Care Disputes and Litigation
April 3, 2023Conference of Tribal Lending Commissioners
March 13, 2023The Antitrust Case that Could Reshape Professional Golf
February 22, 2023A World Without Noncompetes: Protecting Confidential Information and Trade Secrets
February 7, 2023When Monkey Business Slips Into Trademark Infringement
September 16, 2022Uber Company Systems Compromised by Widespread Cyber Hack
September 15, 2022US Averts Rail Workers Strike With Last-Minute Tentative Deal
September 14, 2022Hotter-Than-Expected August Inflation Prompts Massive Wall Street Selloff
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
Christopher Pinahs Joins Robins Kaplan’s Intellectual Property and Technology Group
April 14, 2017
Christopher Pinahs recently joined Robins Kaplan LLP’s Intellectual Property and Technology Litigation Group, where he focuses his practice on patent and trademark litigation. Applying his background in the biological sciences, Pinahs has extensive experience representing clients in the pharmaceutical, medical device, and agricultural arts. In all arenas, Pinahs uses his technical background to help clients develop their case and implement an appropriate strategy to achieve their business goals.
Pinahs’ trial experience includes several significant cases in the health and life sciences industry, including the representation of a generic manufacturer in its challenge of several patents directed to Purdue’s multibillion-dollar OxyContin® product. More recently, Pinahs was a member of a trial team that prevailed on several patents directed to the Alzheimer’s drug, Namenda XR®.
While attending classes at the University of Minnesota Law School, Pinahs simultaneously studied to earn his master’s degree in plant biological studies. He received his J.D. in 2011, and his M.S. in 2012.
Pinahs is active in the legal community, and his involvement includes pro bono representation through the Pro Se Project. He previously served as the chair of the Intellectual Property Practice Group for the Minnesota Federal Bar Association (2015-2016), and currently serves as a member of the Grants Committee for the Minnesota Federal Bar Association.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.